Ribonucleotide reductase: a determinant of 5-bromodeoxyuridine mutagenesis in phage T4.
Mutagenesis by 5-bromodeoxyuridine (BrdUrd) can result from base-pairing errors either during replication of a BrdUrd-containing template or at the nucleotide incorporation step. Replication errors give rise predominantly to AT-to-GC transitions, while incorporation errors, in which 5-bromo-dUTP competes with dCTP at a template guanine site, should give rise to GC-to-AT transitions. The latter pathway should be sensitive to deoxyribonucleoside triphosphate (dNTP) pool fluctuations. Since dNTP pools are regulated through allosteric control of ribonucleotide reductase, the control of this enzyme should be a determinant of BrdUrd mutagenesis--if mutagenesis results largely from incorporation errors. Since T4 phage-encoded ribonucleotide reductase is insensitive to feedback inhibition, we established conditions under which phage DNA replication is dependent upon ribonucleotide reductase of the host, Escherichia coli. We examined BrdUrd mutagenesis of rII mutants known to revert to wild type either by AT-to-GC or GC-to-AT transition pathways. While both reversion pathways were stimulated under all conditions analyzed, the AT-to-GC pathway was stimulated more when the E. coli reductase was functioning, while the GC-to-AT pathway was more specifically enhanced when the T4 reductase was active. These results confirm that ribonucleotide reductase is a determinant of BrdUrd mutagenesis, but our observations, plus experiments showing that BrdUrd has relatively small effects upon dNTP pool sizes, indicate that the relationship between deoxyribonucleotide metabolism and BrdUrd mutagenesis is more complex than anticipated.
Sargent
R G
RG
Department of Biochemistry and Biphysics, Oregon State University, Corvallis 97331.
Ji
J P
JP
Mun
B
B
Mathews
C K
CK
D001973:Bromodeoxyuridine / Q000494:pharmacology*; D003565:Cytidine Diphosphate / Q000378:metabolism; D004252:DNA Mutational Analysis; D004261:DNA Replication; D003853:Deoxyribonucleosides / Q000378:metabolism; D004926:Escherichia coli / Q000187:drug effects / Q000235:genetics; D005796:Genes; D008957:Models, Genetic; D009153:Mutagens / Q000494:pharmacology*; D010710:Phosphates / Q000378:metabolism; D010957:Plasmids; D012264:Ribonucleotide Reductases / Q000235:genetics*; D013604:T-Phages / Q000187:drug effects / Q000235:genetics*
D003853:Deoxyribonucleosides; D009153:Mutagens; D010710:Phosphates; D003565:Cytidine Diphosphate; D012264:Ribonucleotide Reductases; D001973:Bromodeoxyuridine